Proto Labs officer plans $446K share sale
The shares are attributed to restricted stock units that vested from February 13, 2023, through May 20, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Proto Labs, Inc. officer Daniel Schumacher reported an intended sale of 5,000 common shares, with an aggregate market value of $445,650.00, through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through the vesting of restricted stock units from February 13, 2023, through May 20, 2025. His reported prior three-month sales, each identified as a 10b5-1 sale, were 4,900 shares on September 17, 2026, and 100 shares on September 16, 2026.
Key Figures
Key Terms
restricted stock units financial
10b5-1 regulatory
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.